Research article
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer
-
* Corresponding author: Francisco J Esteva festeva@mdanderson.org
1 Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
2 Department of Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
3 Department of Medical Oncology, Hacettepe University Institute of Oncology, Sihhiye St, Ankara 06100, Turkey
4 Department of Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Breast Cancer Research 2007, 9:R87 doi:10.1186/bcr1836
Published: 17 December 2007Additional files
Additional file 1:
Revised intrinsic gene set table.
Format: XLS Size: 642KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 2:
Table of 63 genes featuring the CD40 signaling pathway
Format: XLS Size: 40KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 3:
Complete results from the GSEA
Format: XLS Size: 689KB Download file
This file can be viewed with: Microsoft Excel Viewer